TGFB1 and type 1 diabetes mellitus: In conclusion, our study demonstrates that glucosidase inhibitor, Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes possibly by inhibiting TGF-β/Smad and MAPK signaling pathways and therefore, Nimbidiol may be developed as a promising antidiabetic drug in future.